Prevalence of Transmitted HIV Drug Resistance in Iran between 2010 and 2011
Open Access
- 23 April 2013
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (4), e61864
- https://doi.org/10.1371/journal.pone.0061864
Abstract
Drug-resistant (DR) HIV emerges during combined antiretroviral treatment (cART), creating concern about widespread transmission of DR-HIV as cART is expanded in resource-limited countries. The aim of this study was to determine the predominant HIV-1 subtypes and prevalence of transmitted DR mutations among antiretroviral-naïve patients in Iran.This publication has 17 references indexed in Scilit:
- 2011 update of the drug resistance mutations in HIV-1.2011
- MEGA5: Molecular Evolutionary Genetics Analysis Using Maximum Likelihood, Evolutionary Distance, and Maximum Parsimony MethodsMolecular Biology and Evolution, 2011
- Surveillance of HIV drug resistance transmission in Iran: experience gained from a pilot studyArchiv für die gesamte Virusforschung, 2010
- The Impact of Neuropsychological Functioning on Adherence to HAART in HIV-Infected Substance Abuse PatientsAIDS Patient Care and STDs, 2009
- Drug Resistance Mutations for Surveillance of Transmitted HIV-1 Drug-Resistance: 2009 UpdatePLOS ONE, 2009
- Presence of HIV-1 CRF35_AD in IranAIDS Research and Human Retroviruses, 2009
- A novel sequential sampling technique for the surveillance of transmitted HIV drug resistance by cross-sectional survey for use in low resource settingsAntiviral Therapy, 2008
- World Health Organization/HIVResNet Drug Resistance Laboratory StrategyAntiviral Therapy, 2008
- HIV Type 1 Subtype A Epidemic in Injecting Drug User (IDU) Communities in IranAIDS Research and Human Retroviruses, 2007
- Depressive Symptoms, Neurocognitive Impairment, and Adherence to Highly Active Antiretroviral Therapy Among HIV-Infected PersonsPsychosomatics, 2004